4//SEC Filing
Watts Ryan J. 4
Accession 0001724310-26-000001
CIK 0001714899other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:48 PM ET
Size
8.4 KB
Accession
0001724310-26-000001
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2026-01-03+78,960→ 332,031 total - Award
Stock Option (right to buy)
2026-01-03+236,880→ 236,880 totalExercise: $16.27Exp: 2036-01-03→ Common Stock (236,880 underlying)
Holdings
- 2,152,604(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 25% of the RSUs shall vest on January 3, 2027 (the "Vesting Commencement Date") and an additional 25% of the RSUs shall vest on each annual anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date.
- [F2]Includes 184,915 Unvested RSUs.
- [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- [F4]25% of the shares subject to the option shall vest on January 3, 2027, and 1/48 of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person remaining a service provider of the Issuer through each such date
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724310
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:48 PM ET
- Size
- 8.4 KB